One patient's initial diagnosis was NMO (the diagnosis was based on Wingerchuk‘s clinical 2006 criteria: two absolute criteria were positive and two out of three supportive criteria were positive; serum testing for AQP4‐Ab was not available before this study). This evidence concerns the gene AQP4 and neuromyelitis optica.